Skip to main content
. Author manuscript; available in PMC: 2023 Dec 13.
Published in final edited form as: Circulation. 2022 Nov 2;146(24):e334–e482. doi: 10.1161/CIR.0000000000001106

Recommendations for Acute Medical Management of AAS

Referenced studies that support the recommendations are summarized in the Online Data Supplement.

COR LOE Recommendations
1 B-NR 1. In patients presenting to the hospital with AAS, prompt treatment with anti-impulse therapy with invasive monitoring of BP with an arterial line in an ICU setting is recommended as initial treatment to decrease aortic wall stress.15
1 C-LD 2. Patients with AAS should be treated to an SBP <120 mm Hg or to lowest BP that maintains adequate end-organ perfusion, as well as to a target heart rate of 60 to 80 bpm.3,6
1 B-NR 3. In patients with AAS, initial management should include intravenous beta blockers, except in patients with contraindications.2,5,7

 In those with contraindications or intolerance to beta blockers, initial management with an intravenous non-dihydropyridine calcium channel blocker is reasonable for heart rate control.1,2,5
2a B-NR
1 C-LD 4. In patients with AAS, initial management should include intravenous vasodilators if the BP is not well controlled after initiation of intravenous beta-blocker therapy.8
1 C-EO 5. Patients with AAS should be treated with pain control, as needed, to help with hemodynamic management.